Prescription Monitoring Program Department of Justice
CSFA Number: 444-42-4124
Agency Name
Department Of Human Services (444)
Agency Identification
IDHS-Division of Behavioral Health and Recovery
Agency Contact
Andrew Hollo
217.710.4750
andrew.hollo@illinois.gov
Short Description
This funding opportunity seeks to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency. Please see the Eligible Applicants section for the eligibility criteria.
Federal Authorization
Full-Year Continuing Appropriations Act, 2025 (Pub. L. No. 119-4, Div. A, Secs. 1101(a)(2) and 1301(4), 139 Stat. 9, 10-11, 17; see Pub. L. No. 118-42, 138 Stat. 25, 148-49, para. 15(E)).
Illinois Statue Authorization
N/A
Illinois Administrative Rules Authorization
N/A
Objective
The Harold Rogers Prescription Drug Monitoring Program (PDMP) seeks to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency. PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The primary function of a PDMP is to facilitate the collection, analysis, and reporting of information on the prescribing, dispensing, and use of prescription drugs within a state, commonwealth, district, or territory. The goal of the Harold Rogers PDMP is to strengthen states, commonwealths, districts, and territories’ ability to maintain and enhance their existing PDMPs by accommodating local decision-making based on state laws and preferences and replicate promising practices. As part of supporting the enhancement of PDMPs, the Harold Rogers PDMP supports the integration of PDMP data with health information exchanges (HIE), electronic health records (EHR), or pharmacy dispensing systems (PDS), including engaging with tribal entities and rural areas where integration rates may be lower. This program helps to break the cycle of substance use disorder and violence by reducing the demand for, use, and the illegal trafficking of controlled substances.
Prime Recipient
Yes
UGA Program Terms
N/A
Eligible Applicants
Government Organizations; Education Organizations;
Applicant Eligibility
Eligible applicants must register as a State of Illinois vendor, in good compliance with the comptroller and all state agencies.
Beneficiary Eligibility
N/A
Types of Assistance
Project Grants
Subject / Service Area
Public Safety
Credentials / Documentation
The applicant must submit a completed Application for Federal Assistance including signed assurances that it will comply with statutory and administrative requirements.
Preapplication Coordination
Applicants must have been named in application submitted to Department of Justice.
Application Procedures
Applicants are selected based on the needs of the program.
Criteria Selecting Proposals
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program.
Award Procedures
Upon approval by the Office of Justice Programs, Assistant Attorney General, successful applications will generally be approved or denied within 60 days of receipt of a completed application
Deadlines
N/A
Range of Approval or Disapproval Time
Approximately 60 Days
Appeals
N/A
Renewals
Subject to approval.
Formula Matching Requirements
N/A
Uses and Restrictions
Uses: (A) Improving State prescription drug monitoring programs. (B) Implementing prevention activities and evaluating such activities to identify effective strategies to prevent opioid misuse. (C) Training for health care practitioners, such as best practices for prescribing opioids, pain management, recognizing potential cases of substance use disorder, referral of patients to treatment programs, and overdose prevention. (D) Supporting access to health care services, including those services provided by Federally certified opioid treatment programs or other appropriate health care providers to treat substance use disorders. (E) Other public health-related activities, as the State determines appropriate, related to addressing the opioid misuse crisis within the State.
Reports
Semiannual Financial Reports, Performance Reports, and Close out reports are required.
Audits
Grantee shall be subject to the following audit requirements: 30 ILCS 708/65(c); 44 Ill. Admin. Code 7000.90.
Records
In accordance with the requirements set fourth in 2 CFR 200, Subpart F, grantees must maintain all financial records, supporting documents, statistical records, and all other records pertinent to the award for at least 3 years following the close of the most recent audit.
Account Identification
FY27 Funded Program: 0592.44442.1910.000000NE
Obligations
SFY 27 estimated $1,115,014, SFY 28 estimated $200,000
Range and Average of Financial Assistance
N/A
Program Accomplishments
Forty-nine states, the District of Columbia, and the U.S. territory of Guam have an operational PDMP.
Regulations, Guidelines, and Literature
CFR 200/45 CFR Part 75 Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS awards; also the HHS Grants Policy Statement.
Regional or Local Assistance Location
N/A
Headquarters Office
U.S. Department of Justice; Office of Justice Programs; Bureau of Justice Assistance;810 7th Street, NW, Washington, DC 20531
Program Website
BJA.gov
Example Projects
N/A
Published Date
GATA Exceptions
None
Funding By Fiscal Year
FY 2024 : $229,260
FY 2025 : $439,893
FY 2026 : $628,372
FY 2027 : $1,115,014
FY 2028 : $200,000
Federal Funding
Notice of Funding Opportunities
None
None